CHRISTINA PIERCE: Open Payments
NPI 1831385251 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 16 payments from 9 companies in 2025. Trend: 2023 $672 · 2024 $417 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $282 |
| Incyte Corporation | 2 | $140 |
| Syndax Pharmaceuticals, Inc. | 1 | $113 |
| E.R. Squibb & Sons, L.L.C. | 1 | $103 |
| JAZZ PHARMACEUTICALS INC. | 3 | $83 |
| Legend Biotech USA Inc. | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: RYBREVANT, Niktimvo, REVUFORJ, CARVYKTI, DEFITELIO, LYNOZYFIC, RYLAZE, Vanflyta.
Industry payments across CA — which companies pay providers there.
